Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336 - Moreno-Aspitia, A; Morton, R F; Hillman, D W (J Clin Oncol, 2009)